Randomized trial of intermittent interleukin-2 therapy in HIV-infected patients with CD4 counts >200 cells/mm3. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract LB-8), San Francisco, Sept. 17-20, 1995.NIAID press releases, fact sheets and other materials are available on the internet via the NIAID home page.